|
Originally published In Press as doi:10.1074/jbc.M500041200 on February 3, 2005
J. Biol. Chem., Vol. 280, Issue 15, 14462-14468, April 15, 2005
Evidence for a Role of ADAM17 (TACE) in the Regulation of Platelet Glycoprotein V*
Tamer Rabie ,
Amrei Strehl ,
Andreas Ludwig¶, and
Bernhard Nieswandt ||
From the
Vascular Biology, Rudolf Virchow Center, Deutsche Forschungsgemeinschaft Research Center for Experimental Biomedicine, University of Würzburg, 97078 Würzburg, Germany, and ¶Institute of Biochemistry, Christian Albrecht University Kiel, 24098 Kiel, Germany
Glycoprotein V (GPV) is a subunit of the GPIb-IX-V receptor for von Willebrand factor and thrombin and has been shown to modulate platelet responses to the two strongest physiological agonists, thrombin and collagen. Thrombin directly cleaves GPV from the platelet surface, yielding a 69-kDa fragment GPV f1 of unknown function. We show here that a 82-kDa fragment of GPV is shed from the platelet surface upon cellular activation with phorbol 12-myristate 13-acetate or the collagen-related peptide. This shedding was inhibited by the broad range metalloproteinase inhibitor GM6001, the two potent ADAM17 inhibitors GW280264X and TAPI-2, and was absent in mice lacking functional ADAM17 (ADAM17 lacking Zn-binding domain; ADAM17 Zn/ Zn). Furthermore, we show that recombinant ADAM17 ectodomain efficiently releases GPV from the platelet surface. GPV is known to be associated with the intracellular regulatory protein calmodulin, which has previously been shown to be involved in ADAM17-mediated shedding of L-selectin from the surface of leukocytes. As in these reports, inhibition of calmodulin led to rapid GPV shedding from the platelet surface, a process that was again blocked by GM6001 or ADAM17 inhibitors and that was absent in ADAM17 Zn/ Zn mice. Inhibition of outside-in signaling through GPIIb/IIIa did not significantly affect GPV shedding, excluding an essential role of this pathway for the regulation of ADAM17 activity. These results demonstrate that GPV is cleaved upon agonist-induced platelet activation and show that ADAM17 is the major enzyme mediating this process.
Received for publication, January 3, 2005
, and in revised form, February 2, 2005.
* This work was supported in part by the Deutsche Forschungsgemeinschaft Grants Ni556/4-1 (to B. N.) and LU 869/1-1 (to A. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
|| Heisenberg Fellow of the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed. Tel.: 49-931-201-48996; Fax: 49-931-201-48123; E-mail: bernhard.nieswandt{at}virchow.uniwuerzburg.de.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Brill, A. K. Chauhan, M. Canault, M. T. Walsh, W. Bergmeier, and D. D. Wagner
Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion
Cardiovasc Res,
June 25, 2009;
(2009)
cvp176v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nishikii, K. Eto, N. Tamura, K. Hattori, B. Heissig, T. Kanaji, A. Sawaguchi, S. Goto, J. Ware, and H. Nakauchi
Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells
J. Exp. Med.,
August 4, 2008;
205(8):
1917 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Brass, L. Zhu, and T. J. Stalker
Novel Therapeutic Targets at the Platelet Vascular Interface
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2008;
28(3):
s43 - s50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Gardiner, D. Karunakaran, J. F. Arthur, F.-T. Mu, M. S. Powell, R. I. Baker, P. M. Hogarth, M. L. Kahn, R. K. Andrews, and M. C. Berndt
Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing Fc{gamma}RIIa
Blood,
January 1, 2008;
111(1):
165 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Arthur, Y. Shen, M. L. Kahn, M. C. Berndt, R. K. Andrews, and E. E. Gardiner
Ligand Binding Rapidly Induces Disulfide-dependent Dimerization of Glycoprotein VI on the Platelet Plasma Membrane
J. Biol. Chem.,
October 19, 2007;
282(42):
30434 - 30441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Andrews, D. Karunakaran, E. E. Gardiner, and M. C. Berndt
Platelet Receptor Proteolysis: A Mechanism for Downregulating Platelet Reactivity
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1511 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Jackson
The growing complexity of platelet aggregation
Blood,
June 15, 2007;
109(12):
5087 - 5095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhu, W. Bergmeier, J. Wu, H. Jiang, T. J. Stalker, M. Cieslak, R. Fan, L. Boumsell, A. Kumanogoh, H. Kikutani, et al.
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury
PNAS,
January 30, 2007;
104(5):
1621 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Schulte, H. P. Reusch, M. Pozgajova, D. Varga-Szabo, C. Gachet, and B. Nieswandt
Two-Phase Antithrombotic Protection After Anti-Glycoprotein VI Treatment in Mice
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2006;
26(7):
1640 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Aktas, M. Pozgajova, W. Bergmeier, S. Sunnarborg, S. Offermanns, D. Lee, D. D. Wagner, and B. Nieswandt
Aspirin Induces Platelet Receptor Shedding via ADAM17 (TACE)
J. Biol. Chem.,
December 2, 2005;
280(48):
39716 - 39722.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|